Oyster Point Pharmaceuticals Funding: $300M Raised, IPO
Oyster Point Pharmaceuticals is based in Cambridge, MA. It has raised $300M in total funding. Latest round: IPO.
Oyster Point Pharmaceuticals funding overview
Oyster Point Pharmaceuticals is based in Cambridge, MA. Oyster Point Pharmaceuticals has raised $300M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is an IPO announced in January 2019. The round record for Oyster Point Pharmaceuticals runs through 2019; nothing later has been disclosed.
Oyster Point Pharmaceuticals at a glance
Total raised
$300M
Latest round
IPO
Latest round date
January 2019
Headquarters
Cambridge, MA
Frequently asked about Oyster Point Pharmaceuticals funding
How much has Oyster Point Pharmaceuticals raised?
Oyster Point Pharmaceuticals has raised $300M in total disclosed funding across the rounds on record.
Who has invested in Oyster Point Pharmaceuticals?
No investors are named on the public record for Oyster Point Pharmaceuticals yet.
What was the latest Oyster Point Pharmaceuticals funding round?
The most recent disclosed round is an IPO, announced in January 2019.
Where is Oyster Point Pharmaceuticals based?
Oyster Point Pharmaceuticals is based in Cambridge, MA.
When did Oyster Point Pharmaceuticals last raise?
The last disclosed Oyster Point Pharmaceuticals round closed in January 2019 at IPO.
We update the Oyster Point Pharmaceuticals record whenever a new round is filed or announced, so the totals above track the public record rather than estimates. Related companies in Cambridge and their backers are listed below.
Companies related to Oyster Point Pharmaceuticals (18)
